Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Terlipressin Versus Octreotide in Patients With Hepatorenal Syndrome

NCT07460908 is registered in ClinicalTrials.gov with Lahore General Hospital as lead sponsor.

NCT NCT07460908
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07460908 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Terlipressin Versus Octreotide in Patients With Hepatorenal Syndrome
Lead sponsor
Lahore General Hospital
Phase
Not applicable
Overall status
Completed
Start date
May 1, 2025
Completion date
October 30, 2025
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatorenal syndrome